Minimal-change renal disease and Graves’ disease: a case report and literature review

le Hasnain, Wirasat, Stillman, Isaac E., Bayliss, George P.
Foilsithe in NDT Plus (2011)

Kidney Transplant Outcomes in 2 Adults With Down Syndrome

le Henriksen, Kammi J., Chang, Anthony, Bayliss, George P.
Foilsithe in Kidney Int Rep (2018)

Sodium–glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions

le D’Elia, John A, Segal, Alissa R, Bayliss, George P, Weinrauch, Larry A
Foilsithe in Int J Nephrol Renovasc Dis (2017)

Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study

le Bayliss, George P., Weinrauch, Larry A., Gleason, Ray E., Lee, Annette T., D'Elia, John A.
Foilsithe in Clin Kidney J (2013)

Changes in treatment of hyperglycemia in a hypertensive type 2 diabetes population as renal function declines

le Weinrauch, Larry A., Segal, Alissa R., Bayliss, George P., Liu, Jiankang, Wisniewski, Eric, D’Elia, John A.
Foilsithe in Clin Kidney J (2017)

Kidney Mentoring and Assessment Program for Students: a guide for engaging medical students in nephrology

le Bayliss, George P, Cobb, Jason, Decker, Brian, Hellman, Richard, Vasavada, Nina, Mackelaite, Lina, Shadur, Craig, Ilori, Titilayo, Ibrahim, Tod, Leight, Katlyn, Hsiao, Li-Li, Molitoris, Bruce A, Okusa, Mark D, Parker, Mark G
Foilsithe in Clin Kidney J (2019)

Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

le Chen, Dan-Qian, Cao, Gang, Chen, Hua, Argyopoulos, Christos P., Yu, Hui, Su, Wei, Chen, Lin, Samuels, David C., Zhuang, Shougang, Bayliss, George P., Zhao, Shilin, Yu, Xiao-Yong, Vaziri, Nosratola D., Wang, Ming, Liu, Dan, Mao, Jia-Rong, Ma, Shi-Xing, Zhao, Jin, Zhang, Yuan, Shang, You-Quan, Kang, Huining, Ye, Fei, Cheng, Xiao-Hong, Li, Xiang-Ri, Zhang, Li, Meng, Mei-Xia, Guo, Yan, Zhao, Ying-Yong
Foilsithe in Nat Commun (2019)